Aktiviere Job-Benachrichtigungen per E-Mail!
Erhöhe deine Chancen auf ein Interview
Erstelle einen auf die Position zugeschnittenen Lebenslauf, um deine Erfolgsquote zu erhöhen.
Join a dynamic biopharmaceutical company as a Director of Ex-US Health Economics and Outcomes Research. This role is pivotal in launching and commercializing innovative therapies for rare diseases. You will lead HEOR strategies for mitapivat, ensuring market access and demonstrating product value through robust economic models and evidence generation. Collaborating with cross-functional teams, you will navigate the complexities of global reimbursement landscapes while fostering strong relationships with stakeholders. If you are passionate about making a difference in patient communities and thrive in a flexible, supportive environment, this opportunity is for you.
Director, Ex-US Health Economics and Outcomes Research (HEOR)
Who we are:
Agios is a biopharmaceutical company that is fueled by connections. We thrive in a supportive, fun, and flexible environment full of people empowered to bring their whole selves to work. We care deeply about our work, each other, and the patients who count on us. Our teams cultivate strong bonds with patient communities, healthcare professionals, partners and colleagues, which helps us discover, develop and deliver therapies for rare diseases – and make a bigger difference in their lives. In the U.S., Agios markets a first-in-class pyruvate kinase (PK) activator for the treatment of hemolytic anemia in adults with PK deficiency. Building on the company’s leadership in the field of cellular metabolism, Agios is advancing a robust clinical pipeline of investigational medicines with active and planned programs in alpha- and beta-thalassemia, sickle cell disease, pediatric PK deficiency and MDS-associated anemia.
The impact you will make:
Agios Pharmaceuticals is searching for a dynamic Director, Ex-US Health Economics and Outcomes Research (HEOR)to join our growing HEOR team. We want someone who cares about this important work, and who’s driven to connect to our mission of helping these patient communities. The Director, Ex-US HEOR will be responsible for playing an integral role in the launch and commercialization activities of our expanding GDD portfolio as the HEOR lead for mitapivat launches outside of the US for the pyruvate kinase deficiency, thalassemia and sickle cell disease programs.
What you will do:
The broader HEOR team at Agios is responsible for three pillars of activities:
As the ex-US HEOR launch lead for mitapivat, the successful candidate will be responsible for developing and driving the HEOR strategy and tactical execution of ex-US market access support activities across all three mitapivat indications.They will partner closely with the HEOR indication leads, external distribution partners, and cross-functional partners in market access, clinical development, medical affairs, patient advocacy, and other key Agios functions to develop high quality deliverables that demonstrate product value and differentiate it in a competitive marketplace. Strong economic modeling skills and experience developing HTA-grade models, dossiers, and HTA submissions are required.
The position is best suited for an individual who has the skills and drive to lead and/or collaborate on all HEOR activities to support ex-US launches, the HEOR training and experience to independently manage a a variety of projects with limited oversight, and a desire to serve in a highly regarded and visible role.This role will report to the Senior Director of Health Economics & Outcomes Research.
Responsibilities Will Include, But Are Not Limited To, The Following:
What you bring:
Work Location:
Switzerland/Remote:Work location for this role is remote within Switzerland. Remote employees work entirely from home except for attending Company sponsored events and meetings, and for work related travel as described above.
What we will give you:
Interested in learning more about what makes our culture unique? Visit the Inside Agios section of our website.